{"id":"https://openalex.org/W1578634963","doi":"https://doi.org/10.1111/j.1742-1241.2008.01849.x","title":"Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin","display_name":"Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin","publication_year":2008,"publication_date":"2008-08-11","ids":{"openalex":"https://openalex.org/W1578634963","doi":"https://doi.org/10.1111/j.1742-1241.2008.01849.x","mag":"1578634963","pmid":"https://pubmed.ncbi.nlm.nih.gov/18699842","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2734922"},"language":"en","primary_location":{"id":"doi:10.1111/j.1742-1241.2008.01849.x","doi":"https://doi.org/10.1111/j.1742-1241.2008.01849.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1742-1241.2008.01849.x","pdf_url":null,"source":{"id":"https://openalex.org/S22344484","display_name":"International Journal of Clinical Practice","issn_l":"1368-5031","issn":["1368-5031","1742-1241"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Clinical Practice","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2734922/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108679681","display_name":"Gary G. Kay","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159958","display_name":"Cognitive Research (United States)","ror":"https://ror.org/04s361q55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159958"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. G. Kay","raw_affiliation_strings":["Cognitive Research Corporation, Saint Petersburg, FL 33701, USA. gkay@cogres.com","Cognitive Research Corporation, Saint Petersburg, FL 33701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cognitive Research Corporation, Saint Petersburg, FL 33701, USA. gkay@cogres.com","institution_ids":["https://openalex.org/I4210159958"]},{"raw_affiliation_string":"Cognitive Research Corporation, Saint Petersburg, FL 33701, USA","institution_ids":["https://openalex.org/I4210159958"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040137306","display_name":"Ursula Ebinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"U. Ebinger","raw_affiliation_strings":["Novartis Pharmaceuticals CorporationEast Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals CorporationEast Hanover, NJ, USA","institution_ids":["https://openalex.org/I4210117619"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2350,"currency":"USD","value_usd":2350},"apc_paid":null,"fwci":2.5196,"has_fulltext":false,"cited_by_count":141,"citation_normalized_percentile":{"value":0.91518738,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"62","issue":"11","first_page":"1792","last_page":"1800"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/overactive-bladder","display_name":"overactive bladder","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.7559999823570251},{"id":"https://openalex.org/keywords/darifenacin","display_name":"darifenacin","score":0.9049999713897705},{"id":"https://openalex.org/keywords/oxybutynin","display_name":"oxybutynin","score":0.9779999852180481},{"id":"https://openalex.org/keywords/antimuscarinic-agents","display_name":"antimuscarinic agents","score":0.9279999732971191},{"id":"https://openalex.org/keywords/central-nervous-system-adverse-effects","display_name":"central nervous system adverse effects","score":0.8140000104904175},{"id":"https://openalex.org/keywords/memory","display_name":"memory","score":0.6990000009536743},{"id":"https://openalex.org/keywords/tolterodine","display_name":"tolterodine","score":0.7900000214576721},{"id":"https://openalex.org/keywords/solifenacin","display_name":"solifenacin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/trospium","display_name":"trospium","score":0.9990000128746033},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.7710000276565552},{"id":"https://openalex.org/keywords/neurogenic-bladder","display_name":"neurogenic bladder","score":0.8790000081062317},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.800000011920929},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":1.0}],"concepts":[{"id":"https://openalex.org/C2779502394","wikidata":"https://www.wikidata.org/wiki/Q59575279","display_name":"Solifenacin","level":4,"score":0.9394468069076538},{"id":"https://openalex.org/C2777844464","wikidata":"https://www.wikidata.org/wiki/Q1060922","display_name":"Oxybutynin","level":4,"score":0.9003735780715942},{"id":"https://openalex.org/C2781020410","wikidata":"https://www.wikidata.org/wiki/Q424312","display_name":"Tolterodine","level":4,"score":0.8552019596099854},{"id":"https://openalex.org/C2778941218","wikidata":"https://www.wikidata.org/wiki/Q331231","display_name":"Overactive bladder","level":3,"score":0.8287405967712402},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7765964269638062},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.38076481223106384},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3473438024520874},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06084480881690979},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001572","descriptor_name":"Benzofurans","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001572","descriptor_name":"Benzofurans","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002490","descriptor_name":"Central Nervous System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053201","descriptor_name":"Urinary Bladder, Overactive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D053201","descriptor_name":"Urinary Bladder, Overactive","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1742-1241.2008.01849.x","doi":"https://doi.org/10.1111/j.1742-1241.2008.01849.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1742-1241.2008.01849.x","pdf_url":null,"source":{"id":"https://openalex.org/S22344484","display_name":"International Journal of Clinical Practice","issn_l":"1368-5031","issn":["1368-5031","1742-1241"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Clinical Practice","raw_type":"journal-article"},{"id":"pmid:18699842","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18699842","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical practice","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2734922","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2734922/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int J Clin Pract","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2734922","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2734922/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int J Clin Pract","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320310388","display_name":"Novartis Pharmaceuticals Corporation","ror":"https://ror.org/028fhxy95"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320332736","display_name":"Novartis Pharma","ror":"https://ror.org/0013shd50"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":57,"referenced_works":["https://openalex.org/W1518922051","https://openalex.org/W1556806690","https://openalex.org/W1967347194","https://openalex.org/W1975666765","https://openalex.org/W1980856647","https://openalex.org/W1983993832","https://openalex.org/W1985348849","https://openalex.org/W1985401614","https://openalex.org/W1991693093","https://openalex.org/W1999301355","https://openalex.org/W2005576596","https://openalex.org/W2006909079","https://openalex.org/W2007048466","https://openalex.org/W2008545228","https://openalex.org/W2008618284","https://openalex.org/W2013370441","https://openalex.org/W2014708243","https://openalex.org/W2023939615","https://openalex.org/W2024242239","https://openalex.org/W2025896506","https://openalex.org/W2026522667","https://openalex.org/W2030052255","https://openalex.org/W2030219440","https://openalex.org/W2038287056","https://openalex.org/W2038470517","https://openalex.org/W2039602892","https://openalex.org/W2044040940","https://openalex.org/W2044589919","https://openalex.org/W2047984053","https://openalex.org/W2054058720","https://openalex.org/W2062242064","https://openalex.org/W2067661404","https://openalex.org/W2072160092","https://openalex.org/W2087647828","https://openalex.org/W2088303839","https://openalex.org/W2089864602","https://openalex.org/W2091111772","https://openalex.org/W2092374597","https://openalex.org/W2099958113","https://openalex.org/W2100031431","https://openalex.org/W2105391780","https://openalex.org/W2109033354","https://openalex.org/W2120415574","https://openalex.org/W2126292472","https://openalex.org/W2127863576","https://openalex.org/W2131173377","https://openalex.org/W2134928141","https://openalex.org/W2150628621","https://openalex.org/W2165406034","https://openalex.org/W2326161369","https://openalex.org/W2411419809","https://openalex.org/W2521234232","https://openalex.org/W2782016024","https://openalex.org/W4253276238","https://openalex.org/W4285719527","https://openalex.org/W6644468920","https://openalex.org/W6747433387"],"related_works":["https://openalex.org/W2009999455","https://openalex.org/W3174088411","https://openalex.org/W2941021020","https://openalex.org/W2122121014","https://openalex.org/W4402462423","https://openalex.org/W2052067741","https://openalex.org/W3201279516","https://openalex.org/W2366328854","https://openalex.org/W4391310300","https://openalex.org/W2089864602"],"abstract_inverted_index":{"BACKGROUND:":[0],"Antimuscarinic":[1],"agents":[2],"used":[3],"in":[4,12,83,180,192],"the":[5,31,37,148,190,217,223],"treatment":[6],"of":[7,93,161,174,205,209,222],"overactive":[8],"bladder":[9,229],"(OAB)":[10],"differ":[11],"their":[13],"potential":[14,38],"to":[15,130,153,189],"impair":[16,111],"cognitive":[17,94,103,149,162,178],"function.":[18],"It":[19],"is":[20,158,208],"hypothesised":[21],"that":[22],"low":[23,28],"brain":[24],"concentrations":[25],"and":[26,72,74,79,123,139,197,226],"relatively":[27],"selectivity":[29],"for":[30,39,212],"M(1)":[32,199],"muscarinic":[33,200],"receptor":[34,201],"may":[35,186],"reduce":[36],"adverse":[40],"central":[41],"nervous":[42],"system":[43],"(CNS)":[44],"effects":[45],"with":[46,49,102,134,164,234],"darifenacin,":[47,59],"compared":[48],"other":[50,177],"antimuscarinics,":[51],"particularly":[52],"oxybutynin.":[53],"METHODS:":[54],"Cognitive":[55],"function":[56,95,150],"studies":[57,78,92,145],"evaluating":[58,146],"oxybutynin,":[60,165],"tolterodine,":[61],"solifenacin":[62,138],"and/or":[63],"trospium":[64],"were":[65,85,96,117,128,142],"identified":[66],"from":[67,121],"publications":[68],"databases":[69],"(Medline,":[70],"Biosis":[71],"Embase)":[73],"congress":[75],"abstracts.":[76],"Preclinical":[77],"randomised":[80],"controlled":[81,183],"trials":[82],"adults":[84],"reviewed.":[86],"RESULTS:":[87],"Five":[88],"randomised,":[89,182],"double-blind,":[90],"multiple-dose":[91],"identified.":[97],"Oxybutynin":[98],"was":[99],"consistently":[100],"associated":[101],"deficit":[104],"(four":[105],"studies),":[106],"whereas":[107,166],"darifenacin":[108,167],"did":[109],"not":[110],"cognition":[112],"(three":[113],"studies).":[114],"These":[115],"findings":[116],"supported":[118],"by":[119,170],"data":[120,127],"sleep/attention":[122],"EEG":[124],"studies.":[125],"Tolterodine":[126],"limited":[129],"one":[131],"small":[132],"study":[133],"each":[135],"formulation.":[136],"For":[137],"trospium,":[140],"there":[141],"no":[143,172],"human":[144],"memory,":[147],"most":[151],"vulnerable":[152,213],"CNS":[154,206],"anticholinergics.":[155],"CONCLUSIONS:":[156],"There":[157],"compelling":[159],"evidence":[160],"impairment":[163,173,207],"stands":[168],"out":[169],"demonstrating":[171],"memory":[175],"or":[176,237],"functions":[179],"three":[181],"trials.":[184],"This":[185],"be":[187],"attributed":[188],"differences":[191],"physicochemical":[193],"properties,":[194],"efflux":[195],"mechanisms":[196],"relative":[198],"sparing.":[202],"The":[203],"risk":[204],"particular":[210],"concern":[211],"populations":[214],"such":[215,231],"as":[216,232],"elderly":[218],"(a":[219],"substantial":[220],"proportion":[221],"OAB":[224],"population),":[225],"CNS-compromised":[227],"neurogenic":[228],"patients":[230],"those":[233],"multiple":[235],"sclerosis":[236],"Parkinson's":[238],"disease.":[239]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":16}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}